FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of general formula
, where R1 is a 
or 
or 
or 
group, R2 is morpholine or OR' or N(R")2; R' is a lower alkyl, a lower alkyl substituted with a halogen, or -(CH2)n-cycloalkyl; R" is a lower alkyl; R is NO2 or SO2R'; R4 is hydrogen, hydroxy, halogen, NO2, lower alkoxy, SO2R' or C(O)OR"; R5/R6/R7 denote hydrogen, halogen, lower alkyl; X'/X1 denote CH or N, provided that X1 /X1' are not CH at the same time; X2 is O or S; n equals 0 or 1, and to their pharmaceutically active acid-addition salts. The invention also relates to a drug.
EFFECT: obtaining novel biologically active compounds which are active as glycine transporter 1 inhibitors.
11 cl, 24 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| [4-(HETEROARYL)PIPERAZINE-1-YL]-(2,5-SUBSTITUTED PHENYL)METHANONE DERIVATIVES AS GLYCINE-1 (GLYT-1) CARRIER INHIBITORS FOR TREATING NEUROLOGIC AND PSYCHONEUROLOGICAL DISEASES | 2005 |
|
RU2396270C2 |
| SUBSTITUTED PHENYL METHANONE DERIVATIVES | 2007 |
|
RU2437872C2 |
| 4-PHENOXY-NICOTANIMIDES OR 4-PHENOXY-PYRIMIDINE-5-CARBOXAMIDES | 2011 |
|
RU2565077C2 |
| NEW PHENYLAMIDE OR PYRIDYLAMIDE DERIVATIVES AND USING THEM AS GPBAR1 AGONISTS | 2009 |
|
RU2533887C2 |
| DERIVATIVES OF (3-METHYLPYRROLIDIN-3-YL)-METHYL PYRIDINYL ETHER AND THEIR USE AS ANTAGONISTS OF RECEPTOR NK-3 | 2011 |
|
RU2625798C2 |
| NOVEL BENZODIOXOLS | 2003 |
|
RU2304580C2 |
| QUINOLINE AS ALLOSTERIC ENHENCER OF GABA-B RECEPTORS | 2005 |
|
RU2378256C2 |
| RADIOLABELLED INHIBITORS OF GLICINE 1 TRANSPORTERS | 2009 |
|
RU2512529C2 |
| 1-HYDROXYIMINO-3-PHENYL-PROPANES | 2011 |
|
RU2579114C9 |
| AMINOMETHYL QUINOLONES USEFUL IFOR TREATMENT OF JNK-MEDIATED DISORDER | 2012 |
|
RU2629111C2 |
